DELIVERING VALUE THROUGH INNOVATION IN DIABETES CARE DELIVERY
About 10% of adults live with diabetes in Europe. Despite advances in care, education, medication, tools and technologies, the diabetes prevalence continues to rise, more than one third of people living with diabetes (PWD) remain undiagnosed, and up to half the PwD do not achieve adequate blood glucose management.
Novel approaches in healthcare design, delivery and financing together with technology-led innovation have the potential to address the key barriers to the delivery of high-quality diabetes care and the huge burden to PwD associated with fragmented care. The adoption of innovative tools and approaches and/or their deployment beyond their original setting/at scale is often constrained.
To highlight key innovative developments and ways in which the adoption of innovation can be promoted, IDF Europe launched a new publication:
“Delivering Value through Innovation in Diabetes Care Delivery”
After an introduction by IDF Europe’s co-chair, Nebojsa Lalic, on the current challenges of diabetes care in Europe and the priorities of the diabetes community, our guest panellists shared their experience and insight on how innovation is enabling a transformation in the delivery of diabetes care.
- Sabine Dupont, IDF Europe, Senior Policy Consultant
- Nebojsa Lalic, IDF Europe, co-chair – Priorities of the diabetes community – Download the presentation
- Samuel Chevalier, Diabetes Program Director, Air Liquide Healthcare, France
- Elena Frattolin, Vice-President Diabete Forum, Italy
- Sufyan Hussain, Consultant Physician in Diabetes & Endocrinology, Guy’s & St Thomas’ NHS Foundation Trust, UK
- Partha Kar, National Specialty Advisor, Diabetes GIRFT, NHS England, UK
- João Raposo, Medical Director, Associação Protectora dos Diabéticos de Portugal (APDP), Portugal
- Tim-Morris Schmidt, Advisor for European Affairs to the Director General for Health at Ministère des Solidarités et de la Santé, France
- Nebojsa Lalic, IDF Europe, co-chair
The webinar was moderated by Mark Duman, clinician, management consultant and patient advocate.